Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7261 p170
9 August 2003

This article
Reprint
Photocopy


News summary

Related websites
Proceedings of the National Academy of Sciences abstract (more)


Histone deacetylase inhibitor may prevent pre-term labour in women

Pre-term labour in women could be prevented using a histone deacetylase inhibitor to alter progesterone receptors, say researchers from the University of Texas Southwestern Medical Centre, Dallas.

The researchers have found a way to delay pregnant mice from going into labour for 24–48 hours. This is significant since the average length of gestation in the mouse is only 19 days, and the authors say that the biochemical steps associated with labour are likely to be the same in mice and humans.

Elevated progesterone levels prevent the uterus from contracting throughout a normal pregnancy. The researchers postulate that labour is caused by a number of factors that prevent progesterone from acting. They examined tissues taken from the myometria of women at the end of pregnancy and in labour, and found a marked decline in proteins containing histone acetylase activity at this time. Such activity alters the structure around progesterone-responsive genes, antagonising progesterone receptor function. The researchers found that administration of trichostatin A, a specific and potent histone deacetylase inhibitor, to pregnant mice in late gestation increased histone acetylation in the uterus, allowing the progesterone receptors to continue functioning (Proceedings of the National Academy of Sciences 2003;100:9518).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal